{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:42:34Z","timestamp":1787100154913,"version":"build-2736575974"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ijwd.2021.10.012","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T07:08:32Z","timestamp":1635491312000},"page":"664-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"PB","title":["Clinical considerations in the management of hidradenitis suppurativa in women"],"prefix":"10.1097","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8311-9899","authenticated-orcid":false,"given":"Emily K.","family":"Kozera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-478X","authenticated-orcid":false,"given":"Michelle A.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-3632","authenticated-orcid":false,"given":"John W.","family":"Frew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"3","key":"10.1016\/j.ijwd.2021.10.012_bib0001","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jamadermatol.2019.4162","article-title":"Creation of a registry to address knowledge gaps in hidradenitis suppurativa and pregnancy","volume":"156","author":"Adelekun","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2021.10.012_bib0002","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamadermatol.2020.5162","article-title":"Pregnancy in hidradenitis suppurativa\u2013Patient perspectives and practice gaps","volume":"157","author":"Adelekun","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2021.10.012_bib0003","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijwd.2017.10.007","article-title":"Quality of life and sexual health in patients with hidradenitis suppurativa","volume":"4","author":"Alavi","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2021.10.012_bib0004","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-2133.1996.tb07942.x","article-title":"Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa","volume":"134","author":"Barth","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ijwd.2021.10.012_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.621247","article-title":"Biologics during pregnancy and breastfeeding among women with rheumatic diseases: Evidence on the road","volume":"12","author":"Beltagy","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijwd.2021.10.012_bib0006","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3389\/fimmu.2018.01332","volume":"9","author":"Bereshchenko","year":"2018","journal-title":"sex hormones and immunity. Front Immunol"},{"issue":"10","key":"10.1016\/j.ijwd.2021.10.012_bib0007","doi-asserted-by":"crossref","DOI":"10.5070\/D32310036990","article-title":"Hormonal therapies for hidradenitis suppurativa: Review","volume":"23","author":"Clark","year":"2017","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.ijwd.2021.10.012_bib0008","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijwd.2020.12.002","article-title":"Provider perspectives on the management of hidradenitis suppurativa in pregnancy\u2013A survey study","volume":"7","author":"Collier","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2021.10.012_bib0009","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijwd.2020.09.002","article-title":"Characterizing perimenstrual flares of hidradenitis suppurativa","volume":"6","author":"Collier","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14674","article-title":"Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety","volume":"34","author":"Collier","year":"2021","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0011","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijwd.2020.02.005","article-title":"Special considerations for women with hidradenitis suppurativa","volume":"6","author":"Collier","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.10.012_bib0012","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3390\/jcm8040532","article-title":"Sexual distress in patients with hidradenitis suppurativa: A cross-sectional study","volume":"8","author":"Cuenca-Barrales","year":"2019","journal-title":"J Clin Med"},{"issue":"23","key":"10.1016\/j.ijwd.2021.10.012_bib0013","doi-asserted-by":"crossref","first-page":"8808","DOI":"10.3390\/ijerph17238808","article-title":"Sexuality in patients with hidradenitis suppurativa: Beliefs, behaviors and needs","volume":"17","author":"Cuenca-Barrales","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0014","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000501905","article-title":"Risk factors of sexual dysfunction in patients with hidradenitis suppurativa: A cross-sectional study","volume":"236","author":"Cuenca-Barrales","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.ijwd.2021.10.012_bib0015","article-title":"Hidradenitis suppurativa recurrence in a Caesarean scar","volume":"2020","author":"Darch","year":"2020","journal-title":"Case Rep Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.ijwd.2021.10.012_bib0016","first-page":"209","article-title":"Representation of sex, race and ethnicity in pivotal clinical trials for dermatological drugs","volume":"7","author":"Ding","year":"2021","journal-title":"Int J Womens Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2021.10.012_bib0017","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ijwd.2020.07.002","article-title":"Menses, pregnancy, delivery and menopause in hidradenitis suppurativa: A patient survey","volume":"6","author":"Fernandez","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0018","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdin.2020.05.005","article-title":"Hidradenitis suppurativa is an autoinflammatory keratinization disease: A review of the clinical, histologic, and molecular evidence","volume":"1","author":"Frew","year":"2021","journal-title":"JAAD Int"},{"issue":"7","key":"10.1016\/j.ijwd.2021.10.012_bib0019","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.12688\/f1000research.17267.1","article-title":"A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa","volume":"13","author":"Frew","year":"2018","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.ijwd.2021.10.012_bib0020","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bjd.15441","article-title":"A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa","volume":"177","author":"Frew","year":"2017","journal-title":"Br J Dermatol"},{"issue":"21","key":"10.1016\/j.ijwd.2021.10.012_bib0021","article-title":"Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the U.S. and Canadian Hidradenitis Suppurativa Foundations","volume":"So190\u20139622","author":"Garg","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0022","doi-asserted-by":"crossref","first-page":"939","DOI":"10.2147\/IJWH.S268050","article-title":"Miscarriage as a complication of hidradenitis suppurativa of the vulva","volume":"12","author":"Ghamdi","year":"2020","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.ijwd.2021.10.012_bib0023","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000350056","article-title":"Cumulative life course impairment in other chronic or recurrent dermatologic diseases","volume":"44","author":"Ibler","year":"2020","journal-title":"Curr Probl Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.10.012_bib0024","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/bjd.14975","article-title":"Sexual health and quality of life are impaired in hidradenitis suppurativa: A multicentre cross-sectional study","volume":"176","author":"Janse","year":"2017","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2021.10.012_bib0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijwd.2018.03.001","article-title":"Hidradenitis suppurativa and intimacy","volume":"4","author":"Jemec","year":"2018","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0026","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11154-016-9366-z","article-title":"Hidradenitis suppurativa\/acne inversa: An endocrine skin disorder?","volume":"17","author":"Karagiannidis","year":"2016","journal-title":"Rev Endorc Metab Disord"},{"issue":"4","key":"10.1016\/j.ijwd.2021.10.012_bib0027","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijwd.2019.05.002","article-title":"New changes in pregnancy and lactation labelling: A review of dermatologic drugs","volume":"5","author":"Koh","year":"2019","journal-title":"Int J Womens Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2021.10.012_bib0028","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000453355","article-title":"Quality of life and psychosocial implications in patients with hidradenitis suppurativa","volume":"232","author":"Kouris","year":"2016","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0029","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/bjd.13090","article-title":"Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: A cross-sectional study","volume":"171","author":"Kromann","year":"2014","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2021.10.012_bib0031","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/annrheumdis-2017-212196","article-title":"Lack of placental transfer of cerolizumba pegol during pregnancy: Results from CRIB, a prospective, postmarketing, pharmacokinetic study","volume":"77","author":"Mariette","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0032","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdermsci.2015.10.007","article-title":"Hidradenitis suppurativa may not be associated with venous thromboembolia: Results from a large Danish cross-sectional study","volume":"81","author":"Miller","year":"2016","journal-title":"J Dermatol Sci"},{"issue":"2","key":"10.1016\/j.ijwd.2021.10.012_bib0033","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijwd.2019.11.004","article-title":"A concise clinician's guide to therapy for hidradenitis suppurativa","volume":"6","author":"Nesbitt","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0034","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/jdv.16677","article-title":"Hidradenitis suppurativa: An update on epidemiology, phenotypes, diagnosis, pathogenesis and comorbidities and quality of life","volume":"35","author":"Nguyen","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.10.012_bib0035","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jaad.2016.12.015","article-title":"Disease modification for hidradenitis suppurativa: A new paradigm","volume":"76","author":"Paek","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.ijwd.2021.10.012_bib0036","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.jid.2020.04.011","article-title":"Lipidomics profiling of hidradenitis suppurativa skin lesions reveals lipoxygenase pathway dysregulation and accumulation of proinflammatory leukotriene B4","volume":"140","author":"Penno","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2021.10.012_bib0037","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2016.10.032","article-title":"Management of hidradenitis suppurativa in pregnancy","volume":"76","author":"Perng","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2021.10.012_bib0038","first-page":"239","article-title":"The role of androgens and estrogens in hidradenitis suppurativa\u2013A systematic review","volume":"24","author":"Riis","year":"2016","journal-title":"Acta Dermatovenerol Croat"},{"issue":"21","key":"10.1016\/j.ijwd.2021.10.012_bib0039","article-title":"Outcomes of pregnancy and childbirth in women with hidradenitis suppurativa","volume":"S0190\u20139622","author":"Sakya","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2021.10.012_bib0040","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijwd.2020.04.009","article-title":"The role of virtual support groups for patients with hidradenitis suppurativa during the COVID-19 pandemic","volume":"6","author":"Stout","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0041","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/ar4484","article-title":"Interaction of the endocrine system with inflammation: A function of energy and volume regulation","volume":"16","author":"Straub","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0042","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2021.10.012_bib0043","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijwd.2020.02.006","article-title":"Integrated multidisciplinary approach to hidradenitis suppurativa in clinical practice","volume":"6","author":"Touhouche","year":"2020","journal-title":"Int J Womens Dermatol"},{"issue":"8","key":"10.1016\/j.ijwd.2021.10.012_bib0044","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/rheumatology\/keaa064","article-title":"Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: A systematic review and meta-analysis of observational studies","volume":"59","author":"Tsao","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.ijwd.2021.10.012_bib0045","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jamadermatol.2020.3630","article-title":"Contribution of genetics to the susceptibility to hidradenitis suppurativa in a large, cross-sectional Dutch twin cohort","volume":"156","author":"Van Straalen","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.ijwd.2021.10.012_bib0046","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.3389\/fimmu.2018.02965","article-title":"Hidradenitis suppurativa: A systematic review integrating inflammatory pathways into a cohesive pathogenic model","volume":"14","author":"Vossen","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0048","first-page":"1","article-title":"\u03b3-secretase genetics of hidradenitis suppurativa: A systematic literature review","volume":"17","author":"Wang","year":"2020","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.ijwd.2021.10.012_bib0049","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.14223","article-title":"Nicastrin mutations in familial acne inversa impact keratinocyte proliferation and differentiation through the Notch and phosphoinositide 3-kinase\/AKT signaling pathways","volume":"174","author":"Xiao","year":"2016","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2021.10.012_bib0050","first-page":"838","article-title":"IL-23 promotes the development of castration-resistant prostate cancer","volume":"96","author":"Yan","year":"2018","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"10.1016\/j.ijwd.2021.10.012_bib0051","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/labinvest.2014.69","article-title":"The aldosterone receptor antagonist spironolactone prevents peritoneal inflammation and fibrosis","volume":"94","author":"Zhang","year":"2014","journal-title":"Lab Invest"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521001350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647521001350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T14:25:25Z","timestamp":1641565525000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647521001350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2352647521001350"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.10.012","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical considerations in the management of hidradenitis suppurativa in women","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2021.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}